Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-helicobacter pylori agent with anti-vacuolating toxin activity

Chemotherapy

Volumn 45, Issue 4, 1999, Pages 303-312

  Yamamoto, Yoshimasa ^a   Hakki, Amal ^a   Friedman, Herman ^a   Okubo, Sachie ^b   Shimamura, Tadakatsu ^b   Hoffman, Paul S ^c   Rossignol, Jean François ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antimicrobial agent; Antiparasitic drug; Helicobacter pylori; Nitazoxanide; Vacuolating cytotoxin

Indexed keywords

ANTIPARASITIC AGENT; NITAZOXANIDE; UREASE;

ANTIBACTERIAL ACTIVITY; ARTICLE; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CYTOTOXINS; HELICOBACTER PYLORI; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; THIAZOLES; UREASE; VACUOLES; VIRULENCE;

EID: 0032970973     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007200     Document Type: Article

References (44)

1. Rossignol JF, Maisonneuve H: Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana. Am J Trop Med Hyg 1984;33:511-512.
2. Stockis A, Deroubaix X, Lins R, Jeanbaptiste B, Calderon P, Rossignol JF: Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. Int J Clin Pharmacol Ther 1996;34: 349-351.
3. Kabil SM, Abd El-Salam F, Nsasar A, Abd El-Bast M: Effects of nitazoxanide on the treatment of common human helminthic and protozoal infections. J Trop Med (Egypt) 1994;3:7-10.
4. Cavier R, Rossignol JF: Etude pharmacologique de diverses associations d'anthelmintiques chez la souris. Rev Med Vét 1982;133:779-783.
5. Dubreuil L, Houcke I, Mouton Y, Rossignol JF: In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob Agents Chemother 1996;40:2266-2270.
6. Doumbo O, Rossignol JF, Pichard E, Traore H, Dembele M, Diakite M, Traore F, Diallo AD: Nitazoxanide in the treatment of cryptospordial diarrhea and other intestinal parasitic infections associated with AIDS in tropical Africa. Am J Trop Med Hyg 1997;56:637-639.
7. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn D, Phillips M: Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: Clinical and in vitro studies. J Clin Pathol 1988; 41:207-210.
8. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, Malaty HM: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992;116:705-708.
9. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, Taufer M, Wurzer H: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-312.
10. Brady CE, Hadfield TL, Hyatt JR, Utts SJ: Campylobacter pyloritis - survival in a hostile environment. Am J Gastroenterol 1986;81:855.
11. Blaser MJ: Gastric Campylobacter-like organisms, gastritis and peptic ulcer. Gastroenterology 1987;93: 371-383.
12. Cover TL, Blaser MJ: Helicobacter pylori and gastroduodenal disease. Annu Rev Med 1992;43:135-145.
13. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ: Prevalence of Helicobacter pylori infection and histological gastritis in asymptomatic persons. New Engl J Med 1989; 321:1562-1566.
14. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. New Engl J Med 1991;325:1127-1131.
15. The Eurogast Study Group: An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-1362.
16. Bell G, Powell DK, Weil J, Burridge SM, Morden A, Harrison G: Helicobacter pylori treated with combinations of tripotassium dicitratobismuthate and metronidazole: Efficacy of different regimes and some observations on the emergence of metronidazole resistance. Eur J Gastroenterol Hepatol 1991;3:923-926.
17. Benaïssa M, Babin P, Quellard N, Pezennec L, Cenatiempo Y, Fauchère JL: Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form. Infect Immun 1996;64:2331-2335.
18. Cellini L, Allocati N, Angelucci D, Iezzi T, Campli E, Marzio L, Dainelli B; Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol 1994;38: 843-850.
19. McLaren A: In vitro susceptibility testing of H. pylori; in Clayton CL, Mobley HLT (eds): Methods in Molecular Medicine, Helicobacter pylori Protocols. Totowa, Humana Press, 1997.
20. Megraud F, Trimoulet P, Lamoultiatte H, Boyanova L: Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrob Agents Chemother 1991;35:869-872.
21. Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z, Papini E, Montecucco C, Parente L, Rappuoli R: Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179:1653-1658.
22. Woods GL, Washington JA: Antibacterial susceptibility tests: Dilution and disk diffusion; in Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds): Manual of Clinical Microbiology. Washington, American Society for Microbiology, 1995.
23. Secker DA, Tompkins DS, Alderson G: Gas-permeable lifecell tissue culture flasks give improved growth of Helicobacter pylori in a liquid medium. J Clin Microbiol 1991;29: 1060-1061.
24. Marchini A, d'Apolito M, Massari P, Atzeni M, Copass M, Olivieri R: Cyclodextrins for growth of Helicobacter pylori and production of vacuolating cytotoxin. Arch Microbiol 1995;164:290-293.
25. Hazell SL, Borody TJ, Gal A, Lee A: Campylobacter pyloritis gastritis I: Detection of urease as a marker of bacterial colonization and gastritis. Am J Gastroenterol 1987;82:292-296.
26. Cover T, Puryear LW, Pérez-Pérez GI, Blaser MJ: Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J Infect Dis 1992;166:1073-1078.
27. Cover TL, Dooley CP, Blaser MJ: Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxic activity. Infect Immun 1990;58: 603-610.
28. Hoffman PS, Goodwin A, Johnsen J, Magee K, Veldhuyzen van Zanten SJO: Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: Repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J Bact 1996;178:4822-4829.
29. Pearson RD, Steigbigel RT, Davis HT, Chapman SW: Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother 1980; 18:699-708.
30. Taylor PC, Schoenknecht FD, Sherris JC, Linner EC: Determination of minimum bactericidal concentrations of oxicillin for Staphylococcus aureus: Influence and significance of technical factors. Antimicrob Agents Chemother 1983;23:142-150.
31. Berry V, Jennings K, Woodnutt G: Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob Agents Chemother 1995;39:1859-1861.
32. Andrutis KA, Fox JG, Schauer DB, Marini RP, Murphy JC, Van L, Solnick JV: Inability of an isogenic urease-negative mutant strain of Helicobacter mustelae to colonize the ferret stomach. Infect Immun 1995; 63:3722-3735.
33. Karita M, Tsuda M, Nakagawa T: Essential role of urease in vitro and in vivo Helicobacter pylori colonization study using a wild-type and isogenic urease mutant strain. J Clin Gastroenterol 1995;21:S160-S163.
34. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N: Molecular characterization of the 128-kDa immunodominant antigen of H. pylori associated with cytotoxicity. Proc Natl Acad Sci USA 1993;90:5791-5795.
35. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR: Cytotoxin activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988;26:93-99.
36. Tricottet V, Bruneval P, Vire O, Camilleri JP, Bloch F, Bonte N, Roge J: Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastric in humans: An ultrastructural study. Ultrastruct Pathol 1986;10:113-122.
37. Coudron PE, Stratton CW: Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. Antimicrob Agents Chemother 1995;39: 66-69.
38. Millar MR, Pike J: Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori. Antimicrob Agents Chemother 1992;36:185-187.
39. Slomiany BL, Piotrowski J, Majka J, Slomiany A: Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents. Scand J Gastroenterol 1995;30(suppl 210): 82-84.
40. Catrenich CE, Makin KM: Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms. Scand J Gastroenterol 1991;26(suppl 181): 58-64.
41. Barer MR, Elliott TSJ, Berkeley D, Thomas JE, Eastham EJ: Cytopathic effects of Campylobacter pylori urease. J Clin Pathol 1988;41:597.
42. Cover TL, Puryear W, Perez-Perez GI, Blaser MJ: Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun 1991;59:1264-1270.
43. Ohkuma S, Poole B: Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weekly basic substances. J Cell Biol 1981;90:656-664.
44. Smoot DT, Mobley HLT, Chippendale GR, Lewison JF, Resau JH: Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 1990;58:1992-1994.